Senate Bill 1013 mandates that all public, private, and charter schools in Wisconsin maintain a usable supply of opioid antagonists on-site, ensuring that these life-saving medications are easily accessible at all times. This requirement applies to school boards, governing boards of independent charter schools, and governing bodies of private schools. The bill also stipulates that the Office of School Safety within the Department of Justice will provide grants to these educational institutions to help cover the costs associated with this mandate, with an appropriation of $100,000 allocated for the 2026-27 fiscal year.

The bill introduces new statutory provisions, specifically creating sections 118.07 (1c) and 165.88 (3n) to outline the requirements for maintaining opioid antagonists and the grant funding process. The legislation aims to enhance the safety of students by ensuring that schools are prepared to respond effectively to opioid-related emergencies. The act is set to take effect on September 1, 2026.